CoChat
Sign Up
Cited by 192

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer

Anisimov, Vladimir N., Bartke, Andrzej·2013·Critical Reviews in Oncology/Hematology
DOI 10.1016/j.critrevonc.2013.01.005PMC PMC4095988
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.critrevonc.2013.01.005

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 28 references

Research works printed but not linked: 202

  1. Johnson, 1990, Increased life-span of age-1 mutants in Caenorhabditis elegans and lower Gompertz rate of aging, Science, 249, 908, 10.1126/science.2392681 · DOI
  2. Kenyon, 1993, A C. elegans mutant that lives twice as long as wild type, Nature, 366, 461, 10.1038/366461a0 · DOI · Paper page
  3. Kimura, 1997, daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans, Science, 277, 942, 10.1126/science.277.5328.942 · DOI
  4. Tissenbaum, 1998, An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans, Genetics, 148, 703, 10.1093/genetics/148.2.703 · DOI
  5. Guarente, 2000, Genetic pathways that regulate ageing in model organisms, Nature, 408, 255, 10.1038/35041700 · DOI
  6. Tatar, 2003, The endocrine regulation of aging by insulin-like signals, Science, 299, 1346, 10.1126/science.1081447 · DOI
  7. Conover, 2010, Longevity and age-related pathology of mice deficient in pregnancy-associated plasma protein-A, Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 65, 590, 10.1093/gerona/glq032 · DOI
  8. Blüher, 2003, Extended longevity in mice lacking the insulin receptor in adipose tissue, Science, 299, 572, 10.1126/science.1078223 · DOI · Paper page
  9. Selman, 2011, Replication of extended lifespan phenotype in mice with deletion of insulin receptor substrate 1, PLoS ONE, 6, e16144, 10.1371/journal.pone.0016144 · DOI
  10. Brown-Borg, 1996, Dwarf mice and the aging process, Nature, 384, 33, 10.1038/384033a0 · DOI
  11. Flurkey, 2001, Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production, Proceedings of the National Academy of Sciences of the United States of America, 98, 6736, 10.1073/pnas.111158898 · DOI · Paper page
  12. Coschigano, 2003, Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span, Endocrinology, 144, 3799, 10.1210/en.2003-0374 · DOI · Paper page
  13. Bartke, 2011, Single-gene mutations and healthy ageing in mammals, Philosophical Transactions of the Royal Society of London Series B: Biological Sciences, 366, 28, 10.1098/rstb.2010.0281 · DOI
  14. Ikeno, 2003, Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity, Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 58, 291, 10.1093/gerona/58.4.B291 · DOI
  15. Ikeno, 2009, Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice, Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 64, 522, 10.1093/gerona/glp017 · DOI
  16. Vergara, 2004, Hormone-treated Snell dwarf mice regain fertility but remain long lived and disease resistant, Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 59, 1244, 10.1093/gerona/59.12.1244 · DOI
  17. Kinney, 2001, Evidence that age-induced decline in memory retention is delayed in growth hormone resistant GH-R-KO (Laron) mice, Physiology and Behavior, 72, 653, 10.1016/S0031-9384(01)00423-1 · DOI
  18. Kinney, 2001, Evidence that Ames dwarf mice age differently from their normal siblings in behavioral and learning and memory parameters, Hormones and Behavior, 39, 277, 10.1006/hbeh.2001.1654 · DOI
  19. Anisimov, 1987, vol. 2
  20. Spindler, 2010, Caloric restriction: from soup to nuts, Ageing Research Reviews, 9, 324, 10.1016/j.arr.2009.10.003 · DOI
  21. Anisimov, 2006, Premature ageing prevention: limitations and perspectives of pharmacological interventions, Current Drugs Targets, 7, 1485, 10.2174/1389450110607011485 · DOI
  22. Anisimov, 2009, Carcinogenesis and aging 20 years after: escaping horizon, Mechanisms of Ageing and Development, 130, 105, 10.1016/j.mad.2008.02.004 · DOI
  23. Masoro, 2006, Caloric restriction and ageing, controversial issues, Journal of Gerontology: Biological Sciences, 61A, 14
  24. Barzilai, 2009, Biological approaches to mechanistically understand the healthy life span extension achieved by calorie restriction and modulation of hormones, Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 64, 187, 10.1093/gerona/gln061 · DOI
  25. Roth, 1999, Calorie restriction in primates, will it work and how will we know?, Journal of the American Geriatrics Society, 46, 869
  26. Colman, 2009, Calorie restriction delays disease onset and mortality in rhesus monkeys, Science, 325, 201, 10.1126/science.1173635 · DOI · Paper page
  27. Holloszy, 2007, Caloric restriction in humans, Experimental Gerontology, 42, 709, 10.1016/j.exger.2007.03.009 · DOI
  28. Willcox, 2006, Caloric restriction and human longevity: what can we learn from the Okinawans?, Biogerontology, 7, 173, 10.1007/s10522-006-9008-z · DOI
  29. Braekman, 2006, The dietary restriction effect in C. elegans and humans: is the worm a one-millimeter human?, Biogerontology, 7, 127, 10.1007/s10522-006-9003-4 · DOI
  30. Goto, 2006, Health span extension by later-life caloric or dietary restriction: a view based on rodent studies, Biogerontology, 7, 135, 10.1007/s10522-006-9011-4 · DOI
  31. Le Bourg, 2006, Dietary restriction would probably not increase longevity in human being and other species able to leave unsuitable environments, Biogerontology, 7, 149, 10.1007/s10522-006-9014-1 · DOI
  32. Shanley, 2006, Caloric restriction does not enhance longevity in all species and is unlikely to do so in humans, Biogerontology, 7, 165, 10.1007/s10522-006-9006-1 · DOI
  33. Yu, 2006, Why calorie restriction would work for human longevity, Biogerontology, 7, 179, 10.1007/s10522-006-9009-y · DOI
  34. Anderson, 2012, The caloric restriction paradigm: implications for healthy human aging, American Journal of Human Biology, 24, 101, 10.1002/ajhb.22243 · DOI · Paper page
  35. Anderson, 2010, Metabolic reprogramming, caloric restriction and aging, Trends in Endocrinology & Metabolism, 21, 134, 10.1016/j.tem.2009.11.005 · DOI
  36. Tatar, 2001, A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function, Science, 292, 107, 10.1126/science.1057987 · DOI
  37. Lund, 2002, Transcriptional profile of aging in C. elegans, Current Biology, 12, 1566, 10.1016/S0960-9822(02)01146-6 · DOI
  38. Pinkston-Gosse, 2007, DAF-16/FOXO targets genes that regulate tumor growth in Caenorhabditis elegans, Nature Genetics, 39, 1403, 10.1038/ng.2007.1 · DOI
  39. Pinkston-Gosse, 2006, Mutations that increase the life span of C. elegans inhibit tumor growth, Science, 313, 971, 10.1126/science.1121908 · DOI · Paper page
  40. Lee, 2003, DAF-16 target genes that control C. elegans life-span and metabolism, Science, 300, 644, 10.1126/science.1083614 · DOI · Paper page
  41. Kapeller, 2008, Brain IGF-1 receptors control mammalian growth and life span through a neuroendocrine mechanism, PLoS Biology, 6, e254, 10.1371/journal.pbio.0060254 · DOI
  42. Sharp, 2005, Evidence for down-regulation of phosphoinositide 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR)-dependent translation regulatory signaling pathways in Ames dwarf mice, Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 60, 293, 10.1093/gerona/60.3.293 · DOI · Paper page
  43. Bonkowski, 2009, Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevity, PLoS ONE, 4, e4567, 10.1371/journal.pone.0004567 · DOI
  44. McCormick, 2011, TOR and ageing: a complex pathway for a complex process, Philosophical Transactions of the Royal Society of London Series B: Biological Sciences, 366, 17, 10.1098/rstb.2010.0198 · DOI
  45. Anisimov, 2010, Rapamycin extends maximal life span in cancer-prone mice, American Journal of Pathology, 176, 1092, 10.2353/ajpath.2010.091050 · DOI
  46. Anisimov, 2011, Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice, Cell Cycle, 10, 4230, 10.4161/cc.10.24.18486 · DOI
  47. Salmon, 2005, Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress, American Journal of Physiology: Endocrinology and Metabolism, 289, E23
  48. Panici, 2010, Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice, FASEB Journal, 24, 5073, 10.1096/fj.10-163253 · DOI
  49. Brown-Borg, 2006, Longevity in mice: is stress resistance a common factor?, Age, 28, 145, 10.1007/s11357-006-9003-y · DOI
  50. Sun, 2011, Hepatic response to oxidative injury in long-lived Ames dwarf mice, FASEB Journal, 25, 398, 10.1096/fj.10-164376 · DOI
  51. Murakami, 1996, A genetic pathway conferring life extension and resistance to UV stress in Caenorhabditis elegans, Genetics, 143, 1207, 10.1093/genetics/143.3.1207 · DOI
  52. Lithgow, 1995, Thermotolerance and extended life-span conferred by single-gene mutations and induced by thermal stress, Proceedings of the National Academy of Sciences of the United States of America, 92, 7540, 10.1073/pnas.92.16.7540 · DOI · Paper page
  53. Dekker, 2009, Stress-induced responses of human skin fibroblasts in vitro reflect human longevity, Aging Cell, 8, 595, 10.1111/j.1474-9726.2009.00506.x · DOI
  54. Bokov, 2009, Long-lived Ames dwarf mice are resistant to chemical stressors, Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 64, 819, 10.1093/gerona/glp052 · DOI
  55. Al-Regaiey, 2005, Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor 1/insulin signaling and caloric restriction, Endocrinology, 146, 851, 10.1210/en.2004-1120 · DOI
  56. Westbrook, 2009, Alterations in oxygen consumption, respiratory quotient, and heat production in long-lived GHRKO and Ames dwarf mice, and short-lived bGH transgenic mice, Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 64, 443, 10.1093/gerona/gln075 · DOI · Paper page
  57. Masternak, 2012, Metabolic effects of intra-abdominal fat in GHRKO mice, Aging Cell, 11, 73, 10.1111/j.1474-9726.2011.00763.x · DOI
  58. Franceschi, 2005, Genes involved in immune response/inflammation. IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians, Mechanisms of Ageing and Development, 126, 351, 10.1016/j.mad.2004.08.028 · DOI
  59. Crimmins, 2006, Infection, inflammation, height, and longevity, Proceedings of the National Academy of Sciences of the United States of America, 103, 498, 10.1073/pnas.0501470103 · DOI
  60. Franks, 2012, Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer, Anticancer Research, 32, 1119
  61. Sluczanowska-Glabowska, 2012, Morphology of ovaries in laron dwarf mice, with low circulating plasma levels of insulin-like growth factor-1 (IGF-1), and in bovine GH-transgenic mice, with high circulating plasma levels of IGF-1, Journal of Ovarian Research, 5, 18, 10.1186/1757-2215-5-18 · DOI
  62. Ratajczak, 2011, Higher number of stem cells in the bone marrow of circulating low Igf-1 level Laron dwarf mice—novel view on Igf-1, stem cells and aging, Leukemia, 25, 729, 10.1038/leu.2010.314 · DOI
  63. Ayuk, 2008, Does acromegaly enhance mortality?, Reviews in Endocrine and Metabolic Disorders, 9, 33, 10.1007/s11154-007-9067-8 · DOI
  64. Ross, 2008, Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference?, Obesity Reviews, 9, 312, 10.1111/j.1467-789X.2007.00411.x · DOI
  65. Bartke, 2003, Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice, Neuroendocrinology, 78, 210, 10.1159/000073704 · DOI
  66. Roberts, 1961, The lifetime growth and reproduction of selected strains of mice, Heredity, 16, 369, 10.1038/hdy.1961.46 · DOI
  67. Yuan, 2009, Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels, Aging Cell, 8, 277, 10.1111/j.1474-9726.2009.00478.x · DOI
  68. Miller, 2002, Big mice die young: early life body weight predicts longevity in genetically heterogeneous mice, Aging Cell, 1, 22, 10.1046/j.1474-9728.2002.00006.x · DOI
  69. Rollo, 2002, Growth negatively impacts the life span of mammals, Evolution and Development, 4, 55, 10.1046/j.1525-142x.2002.01053.x · DOI
  70. Patronek, 1997, Comparative longevity of pet dogs and humans: implications for gerontology research, Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 52A, B8, 10.1093/gerona/52A.3.B171 · DOI
  71. Brosnahan, 2003, Demographic and clinical characteristics of geriatric horses: 467 cases (1989–1999), Journal of the American Veterinary Medical Association, 223, 93, 10.2460/javma.2003.223.93 · DOI
  72. Williams, 1957, Pleiotropy, natural selection, and the evolution of senescence, Evolution, 11, 398, 10.2307/2406060 · DOI · Paper page
  73. Besson, 2003, Reduced longevity in untreated patients with isolated growth hormone deficiency, Journal of Clinical Endocrinology and Metabolism, 88, 3664, 10.1210/jc.2002-021938 · DOI
  74. Guevara-Aguirre, 2011, Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans, Science Translational Medicine, 3, 70ra13, 10.1126/scitranslmed.3001845 · DOI
  75. Krzisnik, 2010, Longevity of the hypopituitary patients from the island Krk: a follow-up study, Pediatric Endocrinology Reviews, 7, 357
  76. Aguiar-Oliveira, 2010, Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene, Journal of Clinical Endocrinology and Metabolism, 95, 714, 10.1210/jc.2009-1879 · DOI · Paper page
  77. van Heemst, 2005, Reduced insulin/IGF-1 signaling and human longevity, Aging Cell, 4, 79, 10.1111/j.1474-9728.2005.00148.x · DOI
  78. Willcox, 2008, FOXO3A genotype is strongly associated with human longevity, Proceedings of the National Academy of Sciences of the United States of America, 105, 13987, 10.1073/pnas.0801030105 · DOI · Paper page
  79. Pawlikowska, 2009, Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity, Aging Cell, 8, 460, 10.1111/j.1474-9726.2009.00493.x · DOI
  80. Kojima, 2004, Association analysis between longevity in the Japanese population and polymorphic variants of genes involved in insulin and insulin-like growth factor 1 signaling pathways, Experimental Gerontology, 39, 1595, 10.1016/j.exger.2004.05.007 · DOI
  81. Paolisso, 1996, Glucose tolerance and insulin action in healthy centenarians, American Journal of Physiology, 270, E890
  82. Bonafe, 2003, Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control, Journal of Clinical Endocrinology and Metabolism, 88, 3299, 10.1210/jc.2002-021810 · DOI
  83. Bik, 2006, The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women, Neuroendocrinology Letters, 27, 493
  84. Atzmon, 2006, Lipoprotein genotype and conserved pathway for exceptional longevity in humans, PLoS Biology, 4, e113, 10.1371/journal.pbio.0040113 · DOI
  85. Rozing, 2010, Favorable glucose tolerance and lower prevalence of metabolic syndrome in offspring without diabetes mellitus of nonagenarian siblings: the Leiden longevity study, Journal of the American Geriatrics Society, 58, 564, 10.1111/j.1532-5415.2010.02725.x · DOI
  86. Wijsman, 2011, Familial longevity is marked by enhanced insulin sensitivity, Aging Cell, 10, 114, 10.1111/j.1474-9726.2010.00650.x · DOI
  87. Anisimov, 2001, Age-associated accumulation of the Apolipoprotein C-III gene T-455C polymorphism C allele in a Russian population, Journal of Gerontology: Biological Sciences, 56A, B27
  88. Barbieri, 2003, Glucose regulation and oxidative stress in healthy centenarians, Experimental Gerontology, 38, 137, 10.1016/S0531-5565(02)00153-5 · DOI
  89. Singal, 1983, Potential oxidative pathways of catecholamine in the formation of lipid peroxides and genesis of heart disease, Advances in Experimental Medicine and Biology, 161, 391, 10.1007/978-1-4684-4472-8_22 · DOI
  90. Ruiz-Torres, 2002, Ageing and longevity are related to growth hormone/insulin-like growth factor-1 secretion, Gerontology, 48, 401, 10.1159/000065507 · DOI
  91. Roth, 2002, Biomarkers of caloric restriction may predict longevity in humans, Science, 297, 811, 10.1126/science.1071851 · DOI
  92. Ulrich, 2001, Protein glycation, diabetes, and aging, Recent Progress in Hormone Research, 6, 1, 10.1210/rp.56.1.1 · DOI
  93. Facchini, 2000, Hyperinsulinemia, the missing link among oxidative stress and age-related diseases?, Free Radical Biology and Medicine, 29, 1302, 10.1016/S0891-5849(00)00438-X · DOI
  94. Facchini, 2000, Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols, American Journal of Clinical Nutrition, 72, 776, 10.1093/ajcn/72.3.776 · DOI
  95. Dilman VM, 1978, Ageing, metabolic immunodepression and carcinogenesis, Mechanisms of Ageing and Development, 8, 153, 10.1016/0047-6374(78)90015-5 · DOI
  96. Gennigens, 2006, Insulin-Like Growth Factor (IGF) family and prostate cancer, Critical Reviews in Oncology/Hematology, 58, 124, 10.1016/j.critrevonc.2005.10.003 · DOI
  97. Gupta, 2002, Insulin: a novel factor in carcinogenesis, American Journal of the Medical Sciences, 323, 140, 10.1097/00000441-200203000-00004 · DOI
  98. Pollak, 2007, Insulin-like growth factor-related signaling and cancer development, Recent Results in Cancer Research, 174, 49, 10.1007/978-3-540-37696-5_4 · DOI
  99. Hadley, 2001, Human implications of caloric restriction's effect on laboratory animals: an overview of opportunities for research, Journal of Gerontology A, 56A, 5
  100. Weindruch, 2001, Caloric restriction mimetics, metabolic intervention, Journal of Gerontology Series A: Biological Sciences, 56A, 20, 10.1093/gerona/56.suppl_1.20 · DOI
  101. Blagosklonny, 2006, Aging and immortality, quasi-programmed senescence and its phamacological inhibition, Cell Cycle, 5, 2087, 10.4161/cc.5.18.3288 · DOI
  102. Blagosklonny, 2007, An anti-aging drug today: from senescence-promoting genes to anti-aging pill, Drug Discovery Today, 12, 218, 10.1016/j.drudis.2007.01.004 · DOI
  103. Longo, 2002, Genetics of aging and diseases: from rare mutations and model systems to disease prevention, Archives of Neurology, 59, 1706, 10.1001/archneur.59.11.1706 · DOI
  104. Muntoni, 1974, Inhibition of fatty acid oxidation by biguanides, implication for metabolic physiopathology, Advances in Lipid Research, 12, 311, 10.1016/B978-0-12-024912-1.50014-4 · DOI
  105. Muntoni, 1999, Metformin and fatty acids, Diabetes Care, 22, 179, 10.2337/diacare.22.1.179 · DOI
  106. Dilman, 1982, Metabolic immunodepression and metabolic immunotherapy, an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances, Oncology, 39, 13, 10.1159/000225596 · DOI
  107. Dilman, 1988, Preliminary evidence on metabolic rehabilitation in cancer patients, Archiv fur Geschwulstforschung, 58, 175
  108. Berstein, 2004, Insulin resistance, its consequences for clinical course of the disease and possibilities of correction in endometrial cancer, Journal of Cancer Research and Clinical Oncology, 130, 687, 10.1007/s00432-004-0587-2 · DOI
  109. Berstein, 2005, Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer, Cancer Letters, 224, 203, 10.1016/j.canlet.2004.11.011 · DOI
  110. Berstein, 2010, Modern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond, Future Oncology, 6, 1311, 10.2217/fon.10.87 · DOI
  111. Dilman, 1971, Age-associated elevation of hypothalamic threshold to feedback control and its role in development, aging and disease, Lancet, 1, 1211, 10.1016/S0140-6736(71)91721-1 · DOI
  112. Bakaev, 2002, Effect of 1-butylbiguanide hydrochloride on the longevity in the nematoda Caenorhabditis elegans, Biogerontology, 3 Suppl., 23
  113. Dilman, 1980, Effect of treatment with phenfromin, dyphenylhydantoin or L-DOPA on life span and tumor incidence in C3H/Sn mice, Gerontology, 26, 241, 10.1159/000212423 · DOI
  114. Anisimov, 2005, Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice, Experimental Gerontology, 40, 685, 10.1016/j.exger.2005.07.007 · DOI · Paper page
  115. Anisimov, 2010, Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo, Cell Cycle, 9, 188, 10.4161/cc.9.1.10407 · DOI · Paper page
  116. Anisimov, 2010, Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice, Aging (Albany, NY), 2, 945, 10.18632/aging.100245 · DOI
  117. Anisimov, 2003, Insulin and longevity: antidiabetic biguanides as geroprotectors, Biogerontology, 4, 297, 10.1023/A:1026299318315 · DOI
  118. Anisimov, 1980, Effect of buformin and diphenylhydantoin on life span, estrus function and spontaneous tumor incidence in female rats, Voprosy Onkologii, 6, 42
  119. Smith, 2010, Metformin supplementation and life span in Fischer-344 rats, Journal of Gerontology Series A: Biological Sciences, 65A, 468, 10.1093/gerona/glq033 · DOI · Paper page
  120. Ma, 2007, Metformin therapy in a transgenic mouse model of Hungtington's disease, Neuroscience Letters, 411, 98, 10.1016/j.neulet.2006.10.039 · DOI
  121. Scarpello, 2003, Improving survival with metformin, the evidence base today, Diabetes and Metabolism, 29, 6S36, 10.1016/S1262-3636(03)72786-4 · DOI
  122. Anisimov, 2007, Methods of evaluating the effect of pharmacological drugs on aging and life span in mice, Methods in Molecular Biology, 371, 227, 10.1007/978-1-59745-361-5_17 · DOI
  123. Anisimov, 1975, The increase of hypothalamic sensitivity to the inhibition by estrogens induced by the treatment with L-DOPA, diphenylhydantoin or phenformin in old rats, Bulletin of Experimental Biology and Medicine, 11, 96
  124. Dilman, 1979, Hypothalamic mechanisms of ageing and of specific age pathology—I. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in the reproductive system, Experimental Gerontology, 14, 161, 10.1016/0531-5565(79)90015-9 · DOI
  125. Hung, 2003, Estrogen, synaptic plasticity and hypothalamic reproductive aging, Experimental Gerontology, 38, 53, 10.1016/S0531-5565(02)00183-3 · DOI
  126. Yaghmaie, 2003, A comparison of estrogen receptor-alpha immunoreactivity in the arcuate hypothalamus of young and middle-aged C57BL6 female mice, Experimental Gerontology, 38, 220
  127. Awartani, 2002, Metformin and polycystic ovary syndrome, a literature review, Journal of Obstetrics and Gynaecology Canada, 24, 393, 10.1016/S1701-2163(16)30402-9 · DOI
  128. Nestler, 2002, Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome, Fertility and Sterility, 77, 209, 10.1016/S0015-0282(01)02963-6 · DOI
  129. Fernandes, 2001, Effect of age on elements of insulin-signaling pathway in central nervous system of rats, Endocrine, 16, 227, 10.1385/ENDO:16:3:227 · DOI
  130. Richards, 2002, Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization, Recent Progress in Hormone Research, 57, 195, 10.1210/rp.57.1.195 · DOI
  131. Chiba, 2002, Anti-aging effects of caloric restriction. Involvement of neuroendocrine adaptation by peripheral signaling, Microscopy Research and Technique, 59, 317, 10.1002/jemt.10211 · DOI
  132. Mattson, 2002, How does the brain control lifespan?, Ageing Research Reviews, 1, 155, 10.1016/S1568-1637(01)00003-4 · DOI
  133. McCarty, 1994, Longevity effect of chromium picolinate–‘rejuvenation’ of hypothalamic function?, Medical Hypotheses, 3, 253, 10.1016/0306-9877(94)90076-0 · DOI
  134. De Benedictis, 1998, Gene/longevity association studies at four autosomal loci (REN, THO, PARP, SOD2), European Journal of Human Genetics, 6, 534, 10.1038/sj.ejhg.5200222 · DOI
  135. De Benedictis, 2001, Recent advances in human gene-longevity association studies, Mechanisms of Ageing and Development, 122, 909, 10.1016/S0047-6374(01)00247-0 · DOI
  136. Huxtable, 2000, Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat allels, Diabetes, 49, 126, 10.2337/diabetes.49.1.126 · DOI
  137. Weaver, 1992, Central obesity and hyperinsulinemia in women are associated with polymorphism in the 5′ flanking region of the human insulin gene, European Journal of Clinical Investigation, 22, 265, 10.1111/j.1365-2362.1992.tb01461.x · DOI
  138. Waterworth, 1997, Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome, Lancet, 349, 986, 10.1016/S0140-6736(96)08368-7 · DOI
  139. Tybaierg-Hansen, 1990, Polymorphism in 5′ flanking region of human insulin gene. Relationships with atherosclerosis, lipid levels and age in three samples from Denmark, Arteriosclerosis, 10, 372, 10.1161/01.ATV.10.3.372 · DOI
  140. Rennels, 1965, A cumulative study of the growth of sarcoma 180 in anterior pituitary dwarf mice, Texas Reports on Biology and Medicine, 23, 776
  141. Bielschowsky, 1959, Carcinogenesis in the pituitary dwarf mouse. The response to methylcholanthrene injected subcutaneously, British Journal of Cancer, 13, 302, 10.1038/bjc.1959.36 · DOI
  142. Bielschowsky, 1960, Carcinogenesis in the pituitary dwarf mouse. The response to 2-rminofluorene, British Journal of Cancer, 14, 195, 10.1038/bjc.1960.23 · DOI
  143. Bielschowsky, 1961, Carcinogenesis in the pituitary dwarf mouse. The response to dimethylbenzanthracene applied to the skin, British Journal of Cancer, 15, 257, 10.1038/bjc.1961.32 · DOI
  144. Li, 1990, Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1, Nature, 347, 528, 10.1038/347528a0 · DOI
  145. Sornson, 1996, Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism, Nature, 384, 327, 10.1038/384327a0 · DOI
  146. Zhou, 1997, A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse), Proceedings of the National Academy of Sciences of the United States of America, 94, 13215, 10.1073/pnas.94.24.13215 · DOI
  147. Chen, 1972, Tumorigenesis in strain DW/J mice and induction by prolactin of the group-specific antigen of endogenous C-type RNA tumor virus, Journal of the National Cancer Institute, 49, 1145
  148. Anisimov, 2010, Metformin for aging and cancer prevention, Aging (Albany NY), 2, 760, 10.18632/aging.100230 · DOI
  149. Martin-Castillo, 2010, Metformin and cancer. Doses, mechanisms and the dandelion and hermetic phenomena, Cell Cycle, 9, 1057, 10.4161/cc.9.6.10994 · DOI
  150. Vazquez-Martin, 2010, Metformin and energy metabolism in breast cancer: from insulin physiology to tumour-initiating stem cells, Current Molecular Medicine, 10, 674, 10.2174/156652410792630625 · DOI
  151. Dilman, 1974, On influence of phenformin on induction of mammary tumors in rats, Voprosy Onkologii, 20, 94
  152. Dilman, 1978, Inhibition of DMBA-induced carcinogenesis by phenformin in the mammary gland of rats, Archiv fur Geschwulstforschung, 48, 1
  153. Anisimov, 1980, Inhibition of blastomogenic effect of 7,12-dimethylbenz(a)-anthracene in female rats by buformin, diphenylhydantoin, polypeptide pineal extract and L-DOPA, Bulletin of Experimental Biology and Medicine, 89, 723, 10.1007/BF00836263 · DOI
  154. Anisimov, 1980, Inhibitory effect of phenformin on the development of mammary tumors induced by N-nitrosomethylurea in rats, Experimental Onkology, 3, 40
  155. Bojkova, 2009, Metformin in chemically-induced mammary carcinogenesis in rats, Neoplasma, 56, 269, 10.4149/neo_2009_03_269 · DOI
  156. Zhu, 2011, Metformin as an energy restriction mimetic agent for breast cancer prevention, Journal of Carcinogenesis, 10, 17, 10.4103/1477-3163.83043 · DOI
  157. Deriabina, 2010, Melatonin and metformin inhibits skin carcinogenesis induced by benzo(a)pyrene in mice, Voprosy Onkologii, 56, 583
  158. Man’cheva, 2011, Melatonin and metformin inhibit skin carcinogenesis and lipid perooxidation induced by benzo(a)pyrene in female mice, Bulletin of Experimental Biology and Medicine, 151, 339, 10.1007/s10517-011-1331-y · DOI
  159. Vinnitski, 1981, Effect of phenformin, L-DOPA and para-chlorophenylalanine on the immunological reactivity and chemical carcinogenesis in BALB/c mice, Voprosy Onkologii, 27, 45
  160. Erdemoglu, 2009, Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia, European Journal of Obstetrics, Gynecology, and Reproductive Biology, 145, 195, 10.1016/j.ejogrb.2009.04.034 · DOI
  161. Deriabina, 2010, Melatonin and metformin inhibits development of cervicovaginal tumors induced by benzo(a)pyrene in mice, Morphol Vedomosti, 2, 36
  162. Memmott, 2010, Metformin prevents tobacco carcinogen-induced lung tumorigenesis, Cancer Prevention Research, 3, 1066, 10.1158/1940-6207.CAPR-10-0055 · DOI
  163. Popovich, 2012, Metformin effect on urethane-induced tumorigenesis in mice, Voprosy Onkologii, 58, 549
  164. Bhalla, 2012, Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis, Cancer Prevention Research (Phila), 5, 544, 10.1158/1940-6207.CAPR-11-0228 · DOI
  165. Schneider, 2001, Prevention of pancreatic cancer induction in hamsters by metformin, Gastroenterology, 120, 1263, 10.1053/gast.2001.23258 · DOI
  166. Hou, 2010, Protective effect of metformin in CD1 mice placed on a high carbohydrate-high fat diet, Biochemical and Biophysical Research Communications, 397, 537, 10.1016/j.bbrc.2010.05.152 · DOI
  167. Vitale-Cross, 2012, Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions, Cancer Prevention Research, 5, 562, 10.1158/1940-6207.CAPR-11-0502 · DOI
  168. Huang, 2008, Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice, Biochemistry, 412, 211, 10.1042/BJ20080557 · DOI · Paper page
  169. Hosono, 2010, Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by AMP-activating protein kinase, Molecular Carcinogenesis, 49, 662, 10.1002/mc.20637 · DOI
  170. Shimomoto, 2012, Advanced glycation end products (AGE) induce the receptor for AGE in the colonic mucosa of azoxymethane-injected Fischer 344 rats fed with a high-linoleic acid and high-glucose diet, Journal of Gastroenterology, 47, 1073, 10.1007/s00535-012-0572-5 · DOI
  171. Dilman, 1977, Phenformin elimination of the immunodepression caused by 1,2-dimethylhydrazine in rats, Voprosy Onkologii, 23, 50
  172. Anisimov, 1980, Effect of phenformin on the blastomogenic action of 1,2-dimethylhydrazine in rats, Voprosy Onkologii, 26, 54
  173. Bespalov, 1985, Influence of anticarcinogenic agents on the transplacental carcinogenic effect of N-nitroso-N-ethylurea, Bulletin of Experimental Biology and Medicine, 100, 73, 10.1007/BF00839318 · DOI
  174. Alexandrov, 1980, The inhibition of the transplacental blastomogenic effect of nitrosomethylurea by postnatal administration of buformin to rats, Carcinogenesis, 1, 975, 10.1093/carcin/1.12.975 · DOI
  175. Anisimov, 1982, Inhibition by phenformin of the radiation carcinogenesis in female rats, Experimental Onkology, 4, 26
  176. Wu, 2002, Circulating insulin-like growth factor-1 levels regulate colon cancer growth and metastasis, Cancer Research, 62, 1030
  177. Saydah, 2003, Abnormal glucose tolerance and the risk of cancer death in the United States, American Journal of Epidemiology, 157, 1092, 10.1093/aje/kwg100 · DOI
  178. Lipscombe, 2006, Diabetes mellitus and breast cancer: a retrospective population-based cohort study, Breast Cancer Research and Treatment, 98, 349, 10.1007/s10549-006-9172-5 · DOI
  179. Evans, 2005, Metformin and reduced risk of cancer in diabetic patients, British Medical Journal, 330, 1304, 10.1136/bmj.38415.708634.F7 · DOI · Paper page
  180. Beckman, 1971, Biguanide (Experimental Teil), vol. 29, 439
  181. Wysocki, 2010, Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin, Expert Review of Molecular Diagnostics, 10, 509, 10.1586/erm.10.22 · DOI
  182. Kiho, 2005, Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal, Clinica Chimica Acta, 358, 139, 10.1016/j.cccn.2005.02.012 · DOI
  183. Diamanti-Kandarakis, 2007, Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome, Metabolism: Clinical and Experimental, 6, 129, 10.1016/j.metabol.2006.09.006 · DOI
  184. Nedosugova, 2007, Effect of metformin on oxidative stress rate in type 2 diabetic patients, Probl Endocrinol, 53, 3
  185. Aleisa, 2007, Effect of metformin on clastogenic and biochemical changes induced by adriamycin in Swiss albino mice, Mutation Research, 634, 93, 10.1016/j.mrgentox.2007.06.005 · DOI
  186. Holland, 2004, Metformin (Glucophage) inhibits tyrosine phosphatase activity to stimulate the insulin receptor tyrosine kinase, Biochemical Pharmacology, 67, 2081, 10.1016/j.bcp.2004.02.016 · DOI
  187. Fulgencio, 2001, Effect of metformin on fatty acid and glucose metabolism in freshly isolated hepatocytes and on specific gene expression in cultured hepatocytes, Biochemical Pharmacology, 62, 439, 10.1016/S0006-2952(01)00679-7 · DOI
  188. Heishi, 2006, Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin, Diabetologia, 49, 1647, 10.1007/s00125-006-0271-y · DOI
  189. Kalender, 2010, Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner, Cell Metabolism, 11, 390, 10.1016/j.cmet.2010.03.014 · DOI · Paper page
  190. Spindler, 2006, Use of microarray biomarkers to identify longevity therapeutics, Aging Cell, 5, 39, 10.1111/j.1474-9726.2006.00194.x · DOI
  191. Dhahbi, 2005, Identification of potential caloric restriction mimetics by microarray profiling, Physiological Genomics, 23, 343, 10.1152/physiolgenomics.00069.2005 · DOI · Paper page
  192. Gargiulo, 2002, Metformin decreases platelet superoxide anion production in diabetic patients, Diabetes/Metabolism Research and Reviews, 8, 156, 10.1002/dmrr.282 · DOI
  193. Popovich, 2005, Insulin in aging and cancer: new antidiabetic drug Diabenol as geroprotector and anticarcinogen, International Journal of Biochemistry and Cell Biology, 37, 1117, 10.1016/j.biocel.2004.08.002 · DOI
  194. Solano, 2008, Dehydroepiandrosetrone and metformin regulate proliferation of murine T-lymphocytes, Clinical and Experimental Immunology, 153, 289, 10.1111/j.1365-2249.2008.03696.x · DOI
  195. Morales, 2010, Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway, Kidney International, 77, 861, 10.1038/ki.2010.11 · DOI
  196. Zorov, 2010, Amelioration of aminoglycoside nephrotoxicity requires protection of renal mitochondria, Kidney International, 77, 841, 10.1038/ki.2010.20 · DOI
  197. Attia, 2009, Assessment of genomic instability in normal and diabetic rats treated with metformin, Chemico-Biological Interactions, 180, 296, 10.1016/j.cbi.2009.03.001 · DOI
  198. Diamanti-Kandarakis, 1998, Therapeutic effect of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome, European Journal of Endocrinology, 138, 269, 10.1530/eje.0.1380269 · DOI
  199. Taubes, 2012, Cancer prevention with a diabetes pill?, Science, 335, 29, 10.1126/science.335.6064.29 · DOI
  200. Alimova, 2009, Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro, Cell Cycle, 15, 909, 10.4161/cc.8.6.7933 · DOI · Paper page

200 of 202 shown

Cited by

Sorted by citations

See all 192

Metadata

Authors
Anisimov, V. N., & Bartke, A.
Venue
Critical Reviews in Oncology/Hematology
Publisher
Elsevier BV
Published
2013-09
Volume
87
Issue
3
Pages
201-223
ISSN
1040-8428
DOI
10.1016/j.critrevonc.2013.01.005
PMC
PMC4095988
Cited by
192
References
28
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
President of the Russian Federation (6383.2012.4)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review